Medications to Manage Accelerated Male-Pattern Hair Loss on Testosterone Cypionate: First-Line and Beyond

Does testosterone cypionate cause male-pattern hair loss?

Testosterone cypionate is an FDA-approved injectable testosterone replacement for men with hypogonadism [1]. The Depo-Testosterone label lists male pattern baldness among adverse reactions reported with some androgens and gives no rate [1].

Male-pattern hair loss, or androgenetic alopecia, is a progressive condition in which DHT acts on androgen-sensitive scalp follicles, shortening the growth phase and lengthening the resting phase [5][6]. Testosterone is converted to DHT by 5-alpha reductase; one review states that normally up to 10% of testosterone is converted to DHT [5]. The label notes that in many tissues testosterone's activity appears to depend on reduction to DHT [1].

What is the first-line medication?

Topical minoxidil is FDA-approved for androgenetic alopecia in men, and a meta-analysis found both 5% and 2% minoxidil superior to placebo for hair growth in men [3].

Oral finasteride 1 mg is the other FDA-approved drug for androgenetic alopecia in men; a meta-analysis found it superior to placebo [3]. Finasteride is a 5-alpha reductase inhibitor, the enzyme step that converts testosterone to DHT [5][6][4]. A review lists allergic contact dermatitis, burning, ejaculation disorder and decreased libido among reported drawbacks of minoxidil and finasteride [5].

The FDA approvals for minoxidil and finasteride are for androgenetic alopecia, not for a separate testosterone-related hair-loss diagnosis [3].

What comes after finasteride?

Dutasteride inhibits both type 1 and type 2 5-alpha reductase [4]. It is not FDA-approved for androgenetic alopecia. A review of randomized, double-blind, placebo-controlled trials found dutasteride effective and, in most studies, better than finasteride with comparable adverse effects [4]. Using it for hair loss would be off-label.

Topical finasteride is another option with direct trial data. In a 24-week randomized, double-blind, double-dummy trial of 458 men with androgenetic alopecia, a topical finasteride spray solution increased target-area hair count by 20.2 hairs versus 6.7 with placebo (P<0.001) [2]. The same trial found lower mean serum DHT reduction with topical than oral finasteride (34.5% vs 55.6%) and maximum plasma finasteride concentrations more than 100 times lower [2].

What about supplements and non-drug options?

Saw palmetto is one of several herbal products reviewed for androgenetic alopecia; it is not an FDA-approved treatment [5][3]. Minoxidil and finasteride are the FDA-approved drugs for androgenetic alopecia, and low-level laser therapy is FDA-cleared; a meta-analysis found it superior to placebo [3].